Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Two-stage,Multi-center,Open-label, Randomized,Controlled Trial Comparing the Efficacy and Safety of Intra-peritoneal Infusion of Catumaxomab and Treatment of Investigator Choice in Patients With Advanced Gastric Carcinoma With Peritoneal Metastasis

Next Previous
Search
Trial Profile

A Two-stage,Multi-center,Open-label, Randomized,Controlled Trial Comparing the Efficacy and Safety of Intra-peritoneal Infusion of Catumaxomab and Treatment of Investigator Choice in Patients With Advanced Gastric Carcinoma With Peritoneal Metastasis

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 15 Jul 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Catumaxomab (Primary)
  • Indications Adenocarcinoma; Carcinoma; Gastric cancer; Peritoneal cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors Linton Pharm

    • Most Recent Events

    • 07 Jun 2022 Initial Results (n=17) of safety, pharmacokinetics and efficacy, presented at the 58th Annual Meeting of the American Society of Clinical Oncology
    • 27 May 2022 According to a Linton Pharm media release, data from this study at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.
    • 13 Apr 2021 According to a Linton Pharm media release, the first patient of this study was screened in October 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top